# To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD

> **NCT00064415** · PHASE3 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 799 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Chronic Bronchitis
- Emphysema

## Interventions

- **DRUG:** arformoterol
- **DRUG:** Salmeterol

## Key facts

- **NCT ID:** NCT00064415
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 799 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064415, "To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00064415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*